131 related articles for article (PubMed ID: 9265635)
1. Cisplatin complexes with phosphatidylserine in membranes.
Speelmans G; Staffhorst RW; Versluis K; Reedijk J; de Kruijff B
Biochemistry; 1997 Aug; 36(34):10545-50. PubMed ID: 9265635
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the anti-cancer drug cisplatin with phosphatidylserine in intact and semi-intact cells.
Burger KN; Staffhorst RW; De Kruijff B
Biochim Biophys Acta; 1999 Jun; 1419(1):43-54. PubMed ID: 10366669
[TBL] [Abstract][Full Text] [Related]
3. Strength of Ca(2+) binding to retinal lipid membranes: consequences for lipid organization.
Huster D; Arnold K; Gawrisch K
Biophys J; 2000 Jun; 78(6):3011-8. PubMed ID: 10827979
[TBL] [Abstract][Full Text] [Related]
4. Anticancer cisplatin interactions with bilayers of total lipid extract from pig brain: A13C, 31P and 15N solid-state NMR study.
Jensen M; Nerdal W
Eur J Pharm Sci; 2008 Jul; 34(2-3):140-8. PubMed ID: 18448315
[TBL] [Abstract][Full Text] [Related]
5. The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration.
Speelmans G; Sips WH; Grisel RJ; Staffhorst RW; Fichtinger-Schepman AM; Reedijk J; de Kruijff B
Biochim Biophys Acta; 1996 Aug; 1283(1):60-6. PubMed ID: 8765095
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability.
An X; Guo X; Sum H; Morrow J; Gratzer W; Mohandas N
Biochemistry; 2004 Jan; 43(2):310-5. PubMed ID: 14717584
[TBL] [Abstract][Full Text] [Related]
7. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
[TBL] [Abstract][Full Text] [Related]
8. Membrane composition affects the reversibility of annexin A2t binding to solid supported membranes: a QCM study.
Ross M; Gerke V; Steinem C
Biochemistry; 2003 Mar; 42(10):3131-41. PubMed ID: 12627981
[TBL] [Abstract][Full Text] [Related]
9. Interactions of histone H1 with phospholipids and comparison of its binding to giant liposomes and human leukemic T cells.
Zhao H; Bose S; Tuominen EK; Kinnunen PK
Biochemistry; 2004 Aug; 43(31):10192-202. PubMed ID: 15287747
[TBL] [Abstract][Full Text] [Related]
10. Interaction of hemoglobin with membrane lipids: a source of pathological phenomena.
Shaklai N; Ranney HR
Isr J Med Sci; 1978 Nov; 14(11):1152-6. PubMed ID: 35485
[TBL] [Abstract][Full Text] [Related]
11. The influence of external surface potential and transmembrane potential on the passive transbilayer movement of phospholipids in the red blood cell membrane.
Jänchen G; Libera J; Pomorski T; Müller P; Herrmann A; Bernhardt I
Gen Physiol Biophys; 1996 Oct; 15(5):415-20. PubMed ID: 9228522
[TBL] [Abstract][Full Text] [Related]
12. Changes of phosphatidylserine distribution in human red blood cells during the process of loading sugars.
Quan GB; Liu MX; Ren SP; Zhang JG; Han Y
Cryobiology; 2006 Aug; 53(1):107-18. PubMed ID: 16762335
[TBL] [Abstract][Full Text] [Related]
13. Interaction of bovine erythrocyte spectrin with aminophospholipid liposomes.
Michalak K; Bobrowska M; Sikorski AF
Gen Physiol Biophys; 1993 Apr; 12(2):163-70. PubMed ID: 8405919
[TBL] [Abstract][Full Text] [Related]
14. Lipid structure and not membrane structure is the major determinant in the regulation of protein kinase C by phosphatidylserine.
Johnson JE; Zimmerman ML; Daleke DL; Newton AC
Biochemistry; 1998 Sep; 37(35):12020-5. PubMed ID: 9724512
[TBL] [Abstract][Full Text] [Related]
15. Molecular architecture of nanocapsules, bilayer-enclosed solid particles of Cisplatin.
Chupin V; de Kroon AI; de Kruijff B
J Am Chem Soc; 2004 Oct; 126(42):13816-21. PubMed ID: 15493941
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake.
Liu Q; Qu Y; Van Antwerpen R; Farrell N
Biochemistry; 2006 Apr; 45(13):4248-56. PubMed ID: 16566599
[TBL] [Abstract][Full Text] [Related]
17. Random versus selective membrane phospholipid oxidation in apoptosis: role of phosphatidylserine.
Fabisiak JP; Tyurina YY; Tyurin VA; Lazo JS; Kagan VE
Biochemistry; 1998 Sep; 37(39):13781-90. PubMed ID: 9753467
[TBL] [Abstract][Full Text] [Related]
18. Trifluoperazine causes a disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of pH, acyl unsaturation, and proportion of PS.
Broniec A; Gjerde AU; Ølmheim AB; Holmsen H
Langmuir; 2007 Jan; 23(2):694-9. PubMed ID: 17209622
[TBL] [Abstract][Full Text] [Related]
19. The gas-phase chemistry of cis-diammineplatinum(II) complexes: a joint experimental and theoretical study.
Springer A; Bürgel C; Böhrsch V; Mitrić R; Bonacić-Koutecký V; Linscheid MW
Chemphyschem; 2006 Aug; 7(8):1779-85. PubMed ID: 16847840
[TBL] [Abstract][Full Text] [Related]
20. Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.
Taylor KD; Goel R; Shirazi FH; Molepo M; Popovic P; Stewart DJ; Wong PT
Br J Cancer; 1995 Dec; 72(6):1400-5. PubMed ID: 8519651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
